This story has been updated to include comments from the company's Q4 earnings call.

NEW YORK (GenomeWeb News) – Bruker reported after the close of the market today that its revenues in the fourth quarter were up 7 percent year over year, rising to $552.1 million from $517.3 million in Q4 2012.

The increase was powered largely by the company's BioSpin group, which grew in the double-digits, benefiting from a surge in customer installations and acceptances during the quarter.

The results beat the average Wall Street estimate of $503.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.